El proyecto TuMiCC, que investiga el microambiente tumoral en cáncer de colon, cumple tres años con hallazgos sobre la resistencia a la quimioterapia en un subgrupo de pacientes

by INCLIVA

El proyecto, coordinado por INCLIVA y con la participación del Vall de Hebron Instituto de Oncología (VHIO) y el Instituto Hospital del Mar de Investigaciones Médicas (IMIM-Hospital del Mar), con l...

Read more

Identificadas nuevas dianas terapéuticas para el tratamiento de cáncer de pulmón

by Professional Newco

El grupo de investigación dirigido por el profesor Eugenio Santos, investigador principal del Centro de Investigación del Cáncer (Universidad de Salamanca-CSIC) y de CIBERONC (Instituto de Salud Ca...

Read more

Researchers at CNIO and IDIBELL shed light on the role in lactation of a protein also crucial in breast cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

The new study, led by Eva González-Suárez, head of the Transformation and Metastase Group at the Spanish National Cancer Research Centre (CNIO), describes the behaviour and interaction of these two ...

Read more

Results on the preclinical efficacy of uric acid in ischaemic stroke published

by Fundació Clínic per a la Recerca Biomèdica

The journal Science Translational Medicine has published the results of a preclinical study carried out on rodents that shows the efficacy of uric acid in improving the prognosis of ischaemic stroke. ...

Read more

What research is being done in mental health?

by Fundació Clínic per a la Recerca Biomèdica

Mental disorders are alterations of health that are characterized by a combination of dysfunctions of thoughts, emotions, and behavior, which often make relations with the people around the patient di...

Read more

ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder

by Oryzon Genomics

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company presented an ...

Read more

Researchers from the University's Biodiversity and Environment Institute , Magna and Emgrisa create a decontaminant that irreversibly eliminates Lindane

by Universidad de Navarra

It has been created a compound that facilitates the elimination of Lindane from landfills. Thanks to this research the compound can be used directly on soils to irreversibly decontaminate the affected...

Read more

Cómo mejorar los estilos de vida que afectan a la salud cerebral

by Universidad Politécnica de Madrid

El Grupo de Bioingeniería y Telemedicina de la UPM creará una plataforma tecnológica con inteligencia artificial para identificar los factores involucrados en el cumplimiento de hábitos beneficios...

Read more

Investigadores del IMIBIC caracterizan la obstrucción coronaria, una complicación de los procedimientos TAVI

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

Han llevado a cabo un estudio multicéntrico que concluye que la obstrucción coronaria es una complicación de los procedimientos TAVI, cuya incidencia ha permanecido estable a pesar de la experienci...

Read more

Renalyse has successfully closed an investment round of 1 M€ led by Mind the Gap and with participation from GENESIS Ventures and the Eurostars program

by GENESIS Biomed

Renalyse, also known as CreatSens Health, has concluded an investment round led by the Mind the Gap program of the Botín Foundation, with participation from GENESIS Ventures and the Eurostars program...

Read more

Onalabs incorporates Barça Innovation Hub (BIHUB) into its shareholding as a strategic partner

by Onalabs Inno-Hub

Onalabs Inno-Hub, the startup, a member of CataloniaBio & HealthTech, pioneer in the the development of medical devices capable of reading, measuring, and monitoring physical and biochemical physical ...

Read more

Blocking an immune molecule reduces tumor growth and prolongs survival in animal models of the most aggressive childhood cancer

by CIMA - Centro de Investigación Médica Aplicada

Spanish researchers from Cima and Clínica Universidad de Navarra together with the international cooperative group Diffuse Midline Glioma (DMG-ACT) demonstrate that TIM-3 inhibition promotes immune m...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio preclínico mejora el tratami...

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima Universidad de Navarra constatan que la combin...

Photos Stream